The iRR6 model refines risk stratification for intermediate-1 myelofibrosis patients, incorporating ruxolitinib dosing, spleen reduction, and transfusion needs. Validation in an external cohort ...
China's DeepSeek has launched a new AI model called DeepSeek-V3.2-Exp. The new model comes with the new DeepSeek Sparse Attention technology which the company says is “designed to explore and validate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback